HOME >> BIOLOGY >> NEWS
JCI table of contents -- July 26, 2007

online on July 26 in advance of publication in the August print issue of the Journal of Clinical Investigation, Daniel Rader and colleagues from the University of Pennsylvania studied macrophage reverse cholesterol transport in mice and found that ABCA1 and ABCG1, but not SR-BI, promote reverse cholesterol transport in macrophages and that ABCA1 and ABCG1 have additive effects on this process. The data suggest that ABCA1 and ABCG1 cooperatively contribute to macrophage reverse cholesterol transport and that therapeutic intervention to increase macrophage ABCA1 and ABCG1 expression may be an effective strategy to inhibit the development of, or reduce, atherosclerosis.

TITLE: Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo

AUTHOR CONTACT:

Daniel J. Rader

University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Phone: (215) 573-4176; Fax: (215) 573-8606; E-mail: rader@mail.med.upenn.edu

View the PDF of this article at: https://www.the-jci.org/article.php?id=32057


PHYSIOLOGY

Activation of liver X receptorbeta lowers cholesterol and reverses atherosclerosis

In animals and humans, the proteins known as liver X receptors (LXRs) sense cholesterol levels. Upon sensing increases in cholesterol, these receptors activate signaling pathways that remove diet-derived cholesterol from the body. Two types of LXRs LXR-alpha and LXR-beta are therefore potential targets for the development of anti-atherosclerosis drugs. However, the effects of synthetic drugs that activate these two receptors have not been well studied. In a study appearing online on July 26 in advance of publication in the August print issue of the Journal of Clinical Investigation, Peter Tontonoz and colleagues from the University of Californ
'"/>

Contact: Brooke Grindlinger
press_releases@the-jci.org
734-546-5242
Journal of Clinical Investigation
26-Jul-2007


Page: 1 2 3 4 5 6 7 8

Related biology news :

1. Antioxidant overload may underlie a heritable human disease
2. JCI table of contents: Aug. 9, 2007
3. JCI table of contents: August 1, 2007
4. US Department of Defense awards $1.6 million for implantable biochip research
5. More fish oil, less vegetable oil, better for your health
6. JCI table of contents: July 19, 2007
7. JCI table of contents: July 12, 2007
8. JCI table of contents: June 21, 2007
9. JCI table of contents: June 14, 2007
10. Food safety begins as vegetables grow
11. Turning the tables in chemistry

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/18/2020)... SAN ANTONIO (PRWEB) , ... July 16, 2020 ... ... PLOS ONE that demonstrates the effectiveness of the Invictus Medical Neoasis™ active noise ... (NICU) environment. The study reported that the Neoasis™ device attenuated the alarm sounds ...
(Date:7/4/2020)... ... July 03, 2020 , ... Aesthetics Biomedical ... and multiple awards for not only the products and treatments developed, but also ... Vivace® Microneedle RF. All the brands built by ABM have received several honors ...
(Date:7/1/2020)... ... July 01, 2020 , ... Cure Glioblastoma, a ... most common and aggressive adult brain cancer—announced today the appointments of its first ... charged with supporting the organization’s initiatives and overall vision. , "Senior Fellows are ...
Breaking Biology News(10 mins):
(Date:7/18/2020)... ... July 16, 2020 , ... After research model surgery ... of a great surgery is only the beginning of a successful study, while protecting ... , Join Brad Gien, Global Head of Surgery from Envigo in a ...
(Date:7/10/2020)... ... July 08, 2020 , ... Bode Technology, ... of laboratory operations through its COVID-19 testing service, Bode-CARES . Bode-CARES combines ... Bode-CARES provides a turnkey solution that includes a comprehensive collection and ...
(Date:7/7/2020)... , ... July 06, 2020 , ... R3 International is ... featuring up to 200 million stem cells. Depending on the patient's condition, treatment may ... the US will die having some form of Alzheimers dementia, and the incidence continues ...
(Date:7/1/2020)... ... June 30, 2020 , ... ... that the launch of a new clinical diagnostics immuno-oncology service, TissueInsight ... microenvironment (TME). , “Flagship’s TissueInsight is a service that aids pathologists, oncologists, ...
Breaking Biology Technology:
Cached News: